Newsroom

NIBIB in the News · June 1, 2021
Unlike many other viral testing platforms, MatMaCorp’s all-in-one Solas 8 testing device provides results for six samples in 120 minutes and doesn’t require the additional lab support often lacking in rural areas. To help make the pivot to the human health market, the company applied to the NIH RADx initiative, Source: VentureWell
NIBIB in the News · May 28, 2021
Thinking back to a year ago when terror struck worldwide and the full weight of the Covid-19 pandemic began to set in, NIH quickly mobilized on multiple fronts—one of which was the RADx initiative, with the goal of helping to meet the huge demand for fast, accurate Covid-19 tests. Source: NIH Record.
NIBIB in the News · May 20, 2021
For this episode of the Microsamplify Podcast, we spoke with research scientist Kaitlyn Sadtler, PhD, an Earl Stadtman Tenure-Track Investigator and Chief of the Section for Immunoengineering at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH). In early 2020, Dr. Sadtler and a team of researchers conducted one of the very first serology studies of the novel coronavirus known as SARS-CoV-2, in an effort to identify undetected cases of COVID-19 illness in the United States. Source: Neoteryx
NIBIB in the News · May 6, 2021
Pitt County, North Carolina “is one of two communities in the country that are part of a national study on ramping up at-home testing for coronavirus.” The county “is home to rolling farmland, the city of Greenville, East Carolina University and one of the largest health departments in eastern North Carolina.” Health leaders in the county “said that was why the National Institutes of Health chose the area to test what could be the future of coronavirus screening in the United States.” Source: WRAL=TV Raleigh, NC
NIBIB in the News · May 4, 2021
Chattanooga, TN (WDEF) – The Say Yes! COVID Test At-Home Challenge launched Tuesday. The Hamilton County Health Department, CDC, and National Institute of Health all collaborated for this testing challenge. Source: WDEF News 12 Now
NIBIB in the News · April 23, 2021
Update: The Hamilton County Health Department launched a new initiative to tackle the asymptomatic spread of COVID-19. The "Say Yes! COVID Test" Challenge campaign kicked off on Tuesday. The department partnered with the Center for Disease Control and the National Institute of Health to provide county residents with free, rapid, at-home COVID-19 test kits. Source: WRCBtv
NIBIB in the News · April 16, 2021
The FDA’s approval last month of “two rapid at-home antigen tests, Abbott’s BinaxNOW and Quidel’s QuickVue, [which] will soon be sold over the counter on drugstore shelves, without the need for a prescription.” The article says these approvals have critical potential impact on the testing front and will help the US catch up to other developed nations in terms of rapid antigen testing. The piece highlights comments in an interview by Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering, who said, “We are in a risky period with variant growth, incomplete vaccination, return to school, increased population mobility and reduced mask wearing. ... The need to do screening, using accessible tests at home, on a large scale and on a regular cadence, is even more important.” Source: Scientific American
NIBIB in the News · April 15, 2021
Greenlight Guru, the medtech industry's leading medical device quality management software (MDQMS) platform, today announced its selection as the premier QMS for the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program, led by the National Institute of Biomedical Imaging and Bioengineering. This program aims to improve the speed of innovation in the development, commercialization and implementation of technologies for COVID-19 testing. Source: Prnewswire
NIBIB in the News · April 6, 2021
he US RADx program has spawned a phalanx of diagnostic products to market in just 12 months. Its long-term impact on point-of-care, at-home and population testing may be even more profound. Source: Nature Biotechnology